[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-365913-105":59,"doc-detail-365913-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","disruption-of-constitutive-cxcr4-oligomers-impairs-oncogenic-properties-in-lymphoid-neoplasms","Disruption of constitutive CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasms","","Chemokine receptor CXCR4 overexpression contributes to lymphoid cancer pathogenesis, progression, and therapy resistance, yet the functional meaning of its constitutive oligomerization remained unclear. Using an ananobody-based BRET approach, the study shows that endogenous CXCR4 oligomerization in lymphoid cancer cell lines correlates with higher receptor expression. Selective oligomer disruption decreases basal migration and prosurvival signaling via phosphoproteome changes, suppresses growth of primary CLL 3D spheroids, and increases sensitivity of patient-derived malignant cells to venetoclax.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/disruption-of-constitutive-cxcr4-oligomers-impairs-oncogenic-properties-in-lymphoid-neoplasms/365913/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/disruption-of-constitutive-cxcr4-oligomers-impairs-oncogenic-properties-in-lymphoid-neoplasms/365913.png","ImageObject",300,407,{"name":92,"@type":93},"Fahsai","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How were constitutive CXCR4 oligomers assessed in this study?","Question",{"text":112,"@type":113},"The study used an ananobody-based BRET method to demonstrate constitutive oligomerization of endogenous CXCR4 in lymphoid cancer cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What happens to cell migration and survival signaling when CXCR4 oligomers are disrupted?",{"text":117,"@type":113},"Specific disruption of constitutive CXCR4 oligomers reduces basal cell migration and impairs prosurvival signaling, associated with changes in the phosphoproteome.",{"name":119,"@type":110,"acceptedAnswer":120},"How does oligomer disruption influence venetoclax response in lymphoid neoplasms?",{"text":121,"@type":113},"Oligomer disruption inhibits growth of primary CLL 3D spheroids and sensitizes patient-derived malignant cells to the Bcl-2 inhibitor venetoclax, supporting clinical relevance for improving treatment efficacy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},365913,1790276658,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549768702563,"https://ap-avatar.wpscdn.com/avatar/8000c4aa63b76e948b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786536092046926083","RESEARCH ARTICLE  \nPHARMACOLOGY  \nDisruption of constitutive CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasms  \nSimon Mobacha, b,c,1, Nick D. Bergkampa,1, Ziliang Mad,e,1, Marco V. Haselagerb,c,f, Stephanie M. Anbuhla,g, Daphne Jurriensh, Jelle van den Bora ,  \nZiming Wangi,j, Caitrin Cruddena, Jamie L. Roosb,c,f, Claudia V. Perez Almeriaa , Rick A. Boergonjea, Martin J. Lohsei,j, Reggie Bosmaa, Eric Elderingc,f, k, l, Marco Sideriusa , Wei Wud,e, m, Marcel Spaargarenc, n,o, Sanne H. Toninob,c, Arnon P. Katerb,c, MartineJ. Smita,2, and Raimond Heukersa,g,2  \nAffiliations are included on p. 10.  \nEdited by Robert Lefkowitz, HHMI, Durham, NC; received November 21, 2024; accepted April 4, 2025  \nThe chemokine receptor CXCR4 is overexpressed in many cancers and contributes to pathogenesis, disease progression, and resistance to therapies. CXCR4 is known to formoligomers, but the potential functional relevance in malignancies remains elusive. Using ananobody-based BRET method, we demonstrate that oligomerization ofendogenous CXCR4 on lymphoid cancer cell lines correlates with enhanced expression levels. Specific disruption of CXCR4 oligomers reduced basal cell migration and prosurvival signaling via changes in the phosphoproteome, indicating the existence of constitutive CXCR4 oligomer-mediated signaling. Oligomer disruption also inhibited growth of primary CLL 3D spheroids and sensitized primary malignant cells to clinically used Bcl-2 inhibitor venetoclax. Given its limited efficacy in some patients and the ability to develop resistance, sensitizing malignant B cells to venetoclax is of clinical relevance. Taken together, we established a noncanonical and critical role for CXCR4 oligomers in lymphoid neoplasms and demonstrated that their selective targeting has clinical potential.  \nleukemia | CXCR4 | receptor oligomerization | drug sensitization  \nThe treatment landscape of B cell malignancies like chronic lymphocytic leukemia (CLL) has undergone significant transformations after the introduction of effective oral targeted therapies such as BTK-, PI3K-, and Bcl-2 inhibitors (venetoclax) and next-generation anti-CD20 monoclonal antibodies (1). Nevertheless, the unresponsiveness of some patients, along with acquired resistance and the nearly universal subsequent relapse of the disease, underscores the ongoing need for a potentially curative treatment (2). The chemokine receptor CXCR4 is overexpressed in many human cancers, including lymphoid neoplasms. In these disease states, CXCR4 induces signaling that promotes tumor survival and metastasis upon activation by its endogenous ligand CXCL12 (3) . In CLL, CXCR4 was shown to promote a protective tumor microenvironment by allowing migration into the lymph node and altering the behavior of adjacent cells to support tumor survival and growth (4) . CXCR4 signaling also drives the retention of malignant cells in the bone marrow, thereby protecting these cells from chemotoxic stress and targeted therapies administered (5–7) . These observations support a central critical role for CXCR4 signaling in the biology of lymphoid neoplasms and position CXCR4 as an important drug target to treat such diseases (8, 9) .  \nCXCR4 belongs to the class A G protein–coupled receptors (GPCRs). Since GPCRs regulate numerous (patho-)physiological processes and are highly amenable to drug intervention, they represent a major class of drug targets (10). Although classically perceived as monomeric signaling units, GPCRs are increasingly recognized to exist and signal as dimers or as higher-order oligomeric complexes (11). For example, it is well established that the functionality of class C GPCRs is critically dependent on the formation of homo-and heterodimers (12, 13). In contrast, the role of oligomerization in regulating receptor function and influencing downstream signaling outcomes remains unclear for the larger class A GPCR family. Some class A GPCRs appear to form transient dimers and ","cbCaid3NWVM6DbrD","https://ap.wps.com/l/cbCaid3NWVM6DbrD","pdf",3025232,11,"English","# Background\n## CXCR4 in B cell malignancies\n## GPCR oligomerization and receptor signaling\n# Methods and Key Findings\n## Nanobody-based BRET to assess CXCR4 oligomers\n## Effects of oligomer disruption on signaling and tumor behavior\n# Clinical Relevance\n## Venetoclax sensitization in primary malignant cells","[{\"question\":\"How were constitutive CXCR4 oligomers assessed in this study?\",\"answer\":\"The study used an ananobody-based BRET method to demonstrate constitutive oligomerization of endogenous CXCR4 in lymphoid cancer cells.\"},{\"question\":\"What happens to cell migration and survival signaling when CXCR4 oligomers are disrupted?\",\"answer\":\"Specific disruption of constitutive CXCR4 oligomers reduces basal cell migration and impairs prosurvival signaling, associated with changes in the phosphoproteome.\"},{\"question\":\"How does oligomer disruption influence venetoclax response in lymphoid neoplasms?\",\"answer\":\"Oligomer disruption inhibits growth of primary CLL 3D spheroids and sensitizes patient-derived malignant cells to the Bcl-2 inhibitor venetoclax, supporting clinical relevance for improving treatment efficacy.\"}]","Disruption of constitutive CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasms | PDF",1790162909,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fe80519c80e6cb569fb7116cbd5a8ca0.webp",983,1316,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7152651ffbc0409404d6b4209a503e21.webp",982,1315,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/80713bb0006b3980df80e0979f472e83.webp",981,1313,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/445302c00f71e2a51d98216ea6b24317.webp",980,1312]